Media is reporting that on 9 July, University of Illinois at Chicago (UIC) will begin a clinical trial of a potential COVID-19 vaccine. The trial is overseen by the National Institute of Allergy and Infectious Diseases (NIAID), and hopes to enroll at least 30,000 individuals. UIC will enroll at least 1,000 participants, nearly half of which are to be at least 65 years of age.